Ulrike Baumer, Lea Pedarnig, Andreas Hammer, Eva Steinacher, Niema Kazem, Lorenz Koller, Ulrike Pailer, René Rettl, Gere Sunder-Plassmann, Alice Schmidt, Christian Hengstenberg, Patrick Sulzagruber, Alexander Niessner, Felix Hofer
{"title":"心房颤动患者心衰和慢性肾脏疾病的预后相互作用——以心肾预后为重点。","authors":"Ulrike Baumer, Lea Pedarnig, Andreas Hammer, Eva Steinacher, Niema Kazem, Lorenz Koller, Ulrike Pailer, René Rettl, Gere Sunder-Plassmann, Alice Schmidt, Christian Hengstenberg, Patrick Sulzagruber, Alexander Niessner, Felix Hofer","doi":"10.1159/000548380","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>HF and CKD create a mutually reinforcing cycle, escalating disease development, and increasing morbidity and mortality rates. Both are common comorbidities promoting AF and contributing to heightened symptom burden and poorer outcomes in AF. Here our aim was to investigate the relationship of heart failure (HF) and chronic kidney disease (CKD) with cardiorenal outcomes in patients with atrial fibrillation (AF).</p><p><strong>Methods: </strong>Patients with AF, treated at a tertiary centre between 01/2005 and 07/2019 were included. The primary endpoint was a composite of cardiovascular (CV) death and hospitalization for HF (HHF). Secondary outcomes were the individual components of the primary endpoint, all-cause death, renal death, and dialysis.</p><p><strong>Results: </strong>We included in total 7412 patients (median age 70 years, 39.7% female) with AF and followed them over a median of 4.5 years. There was a significant stepwise increase in 5-year's event rates for the composite of CV death/ HHF (no CKD & no HF: 23%, HF: 61%, CKD: 63%, CKD & HF: 82%; P-logrank <0.001). Both CKD (adjusted HR 1.87, 95% CI 1.55-2.25) and HF (adjusted HR 2.57, 95% CI 2.22-2.98) were significantly associated with CV death/ HHF after multivariable adjustment. A similar association was observed for the individual components of the primary endpoint and renal death/ dialysis.</p><p><strong>Conclusions: </strong>Both CKD and HF significantly increase the risk of CV death and HHF, as well as renal death/ dialysis in patients with AF. Risk assessment should expand beyond stroke and bleeding to cardiorenal complications including HHF, CV and renal death, as well as kidney failure.</p>","PeriodicalId":9584,"journal":{"name":"Cardiorenal Medicine","volume":" ","pages":"1-22"},"PeriodicalIF":2.9000,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Prognostic Interplay of Heart Failure and Chronic Kidney Disease in Atrial Fibrillation - Focus on Cardiorenal Outcomes.\",\"authors\":\"Ulrike Baumer, Lea Pedarnig, Andreas Hammer, Eva Steinacher, Niema Kazem, Lorenz Koller, Ulrike Pailer, René Rettl, Gere Sunder-Plassmann, Alice Schmidt, Christian Hengstenberg, Patrick Sulzagruber, Alexander Niessner, Felix Hofer\",\"doi\":\"10.1159/000548380\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>HF and CKD create a mutually reinforcing cycle, escalating disease development, and increasing morbidity and mortality rates. Both are common comorbidities promoting AF and contributing to heightened symptom burden and poorer outcomes in AF. Here our aim was to investigate the relationship of heart failure (HF) and chronic kidney disease (CKD) with cardiorenal outcomes in patients with atrial fibrillation (AF).</p><p><strong>Methods: </strong>Patients with AF, treated at a tertiary centre between 01/2005 and 07/2019 were included. The primary endpoint was a composite of cardiovascular (CV) death and hospitalization for HF (HHF). Secondary outcomes were the individual components of the primary endpoint, all-cause death, renal death, and dialysis.</p><p><strong>Results: </strong>We included in total 7412 patients (median age 70 years, 39.7% female) with AF and followed them over a median of 4.5 years. There was a significant stepwise increase in 5-year's event rates for the composite of CV death/ HHF (no CKD & no HF: 23%, HF: 61%, CKD: 63%, CKD & HF: 82%; P-logrank <0.001). Both CKD (adjusted HR 1.87, 95% CI 1.55-2.25) and HF (adjusted HR 2.57, 95% CI 2.22-2.98) were significantly associated with CV death/ HHF after multivariable adjustment. A similar association was observed for the individual components of the primary endpoint and renal death/ dialysis.</p><p><strong>Conclusions: </strong>Both CKD and HF significantly increase the risk of CV death and HHF, as well as renal death/ dialysis in patients with AF. Risk assessment should expand beyond stroke and bleeding to cardiorenal complications including HHF, CV and renal death, as well as kidney failure.</p>\",\"PeriodicalId\":9584,\"journal\":{\"name\":\"Cardiorenal Medicine\",\"volume\":\" \",\"pages\":\"1-22\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-09-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiorenal Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000548380\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiorenal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000548380","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
The Prognostic Interplay of Heart Failure and Chronic Kidney Disease in Atrial Fibrillation - Focus on Cardiorenal Outcomes.
Background: HF and CKD create a mutually reinforcing cycle, escalating disease development, and increasing morbidity and mortality rates. Both are common comorbidities promoting AF and contributing to heightened symptom burden and poorer outcomes in AF. Here our aim was to investigate the relationship of heart failure (HF) and chronic kidney disease (CKD) with cardiorenal outcomes in patients with atrial fibrillation (AF).
Methods: Patients with AF, treated at a tertiary centre between 01/2005 and 07/2019 were included. The primary endpoint was a composite of cardiovascular (CV) death and hospitalization for HF (HHF). Secondary outcomes were the individual components of the primary endpoint, all-cause death, renal death, and dialysis.
Results: We included in total 7412 patients (median age 70 years, 39.7% female) with AF and followed them over a median of 4.5 years. There was a significant stepwise increase in 5-year's event rates for the composite of CV death/ HHF (no CKD & no HF: 23%, HF: 61%, CKD: 63%, CKD & HF: 82%; P-logrank <0.001). Both CKD (adjusted HR 1.87, 95% CI 1.55-2.25) and HF (adjusted HR 2.57, 95% CI 2.22-2.98) were significantly associated with CV death/ HHF after multivariable adjustment. A similar association was observed for the individual components of the primary endpoint and renal death/ dialysis.
Conclusions: Both CKD and HF significantly increase the risk of CV death and HHF, as well as renal death/ dialysis in patients with AF. Risk assessment should expand beyond stroke and bleeding to cardiorenal complications including HHF, CV and renal death, as well as kidney failure.
期刊介绍:
The journal ''Cardiorenal Medicine'' explores the mechanisms by which obesity and other metabolic abnormalities promote the pathogenesis and progression of heart and kidney disease (cardiorenal metabolic syndrome). It provides an interdisciplinary platform for the advancement of research and clinical practice, focussing on translational issues.